PROCEPT BioRobotics (PRCT) - 2024 Q1 - Quarterly Results

PROCEPT BioRobotics Reports First Quarter 2024 Financial Results and Increases 2024 Revenue Guidance SAN JOSE, Calif., May 1, 2024 -- PROCEPT® BioRobotics Corporation (Nasdaq: PRCT) (the "Company"), a surgical robotics company focused on advancing patient care by developing transformative solutions in urology, today reported unaudited financial results for the quarter ended March 31, 2024. Recent Highlights Net loss was $26.0 million for the first quarter of 2024, compared to a loss of$28.5 million in the ...